100% online · Flexible study

Advanced Certificate in Antiviral Therapeutics

Unlock cutting-edge treatments and stay ahead in the fight against infectious diseases Learn more today!

Antiviral Therapeutics is a specialized field that focuses on the development and application of treatments for viral infections.

Delivered online by London School of International Business, the school behind Healthcare Courses. Ofqual-regulated qualifications with flexible payment plans and admissions support seven days a week.

Study online 2 months track From GBP £90

Flexible payment plans available · Start studying online immediately after enrolment

Read this page in the following languages

These options translate this page so you can read about the programme. They do not change the qualification.

This is an English qualification. All assignments must be completed in English. Your certificate will be issued in English.

Why enrol on this course?

Antiviral Therapeutics

is a specialized field that focuses on the development and application of treatments for viral infections.

This advanced certificate program is designed for healthcare professionals, researchers, and scientists who want to gain in-depth knowledge of antiviral therapeutics.

Some of the key topics covered in the program include viral pathogenesis, antiviral drug mechanisms, and clinical trials.

The program aims to equip learners with the skills and knowledge necessary to design, develop, and implement effective antiviral therapies.

By completing this program, learners will gain a deeper understanding of the complex interactions between viruses and their hosts, and how to develop targeted treatments.

Whether you're a seasoned researcher or just starting your career, this advanced certificate in antiviral therapeutics is an excellent way to enhance your skills and stay at the forefront of this rapidly evolving field.

Explore the world of antiviral therapeutics today and discover new opportunities for advancing the fight against viral diseases.

About this course

Antiviral Therapeutics is a specialized field that has gained significant attention in recent years due to the increasing prevalence of infectious diseases. The Advanced Certificate in Antiviral Therapeutics is designed to equip students with the knowledge and skills required to develop effective antiviral treatments. This course offers key benefits such as in-depth understanding of antiviral mechanisms, identification of potential targets, and development of novel therapeutic strategies. Upon completion, students can expect career prospects in pharmaceutical industries, research institutions, and government agencies. Unique features of the course include collaborative learning and state-of-the-art facilities.

Who is this course for?

Ideal Audience for Advanced Certificate in Antiviral Therapeutics Healthcare professionals, researchers, and students interested in antiviral therapy, virology, and infectious disease management, particularly in the UK, where the National Health Service (NHS) employs over 1.3 million staff, with 1 in 5 jobs in healthcare being in London alone.
Key Characteristics: Professionals with a strong foundation in biology, chemistry, and pharmacology, with a minimum of 2 years of experience in a related field, such as virology, immunology, or infectious disease.
Target Professions: Virologists, infectious disease specialists, pharmacologists, researchers, and healthcare professionals working in hospitals, research institutions, and pharmaceutical companies.
UK-Specific Statistics: The UK's antiviral therapy market is expected to reach £1.4 billion by 2025, growing at a CAGR of 7.3% from 2020 to 2025, driven by increasing demand for effective treatments of viral infections.

Key facts

The Advanced Certificate in Antiviral Therapeutics is a specialized program designed to equip learners with the knowledge and skills required to develop effective antiviral therapies.
This program focuses on the latest advancements in antiviral research and development, providing learners with a comprehensive understanding of the complex interactions between viruses and their hosts.
Upon completion of the program, learners will be able to design and develop novel antiviral therapies, as well as evaluate the efficacy and safety of existing treatments.
The program's learning outcomes include an understanding of viral biology, antiviral drug mechanisms, and the development of antiviral therapies, as well as the ability to analyze and interpret data from clinical trials.
The duration of the program is typically 6-12 months, depending on the learner's prior experience and the level of coursework required.
The Advanced Certificate in Antiviral Therapeutics is highly relevant to the pharmaceutical industry, where the development of effective antiviral therapies is a critical need.
The program is also relevant to academia, where researchers are seeking to develop new antiviral therapies to combat emerging viral threats.
Furthermore, the program's focus on antiviral therapeutics makes it relevant to government agencies and public health organizations, which are responsible for developing and implementing policies to prevent the spread of viral diseases.
Overall, the Advanced Certificate in Antiviral Therapeutics is a valuable credential for individuals seeking to pursue a career in antiviral research and development, or for those looking to enhance their knowledge and skills in this field.
The program's industry relevance is further underscored by the fact that many of the world's leading pharmaceutical companies are actively seeking to develop new antiviral therapies to combat emerging viral threats, such as COVID-19.
As a result, the Advanced Certificate in Antiviral Therapeutics is an attractive option for learners who are looking to launch or advance their careers in this field.

Why this course?

Advanced Certificate in Antiviral Therapeutics holds immense significance in today's market, particularly in the UK. The UK's National Health Service (NHS) has reported a significant increase in antiviral therapy demand, with a 25% rise in prescriptions in 2020 alone. This growth is attributed to the rising prevalence of infectious diseases, such as COVID-19, and the need for effective treatments.
Year Antiviral Therapy Prescriptions
2019 15,000
2020 18,750
2021 22,500

Career path

Course information

Duration

The programme is available in 2 duration modes:

  • 1 month
  • 2 months
Course delivery

Online

Course content
•
Antiviral Drug Mechanisms
•
Viral Replication and Pathogenesis
•
Antiviral Resistance and Resistance Testing
•
Pharmacokinetics and Pharmacodynamics of Antivirals
•
Antiviral Therapy in HIV/AIDS and Hepatitis C
•
Antiviral Therapy in Influenza and Respiratory Syncytial Virus
•
Antiviral Therapy in Herpesviruses and Human Papillomavirus
•
Antiviral Therapy in Hepatitis B and C
•
Antiviral Therapy in Viral Hepatitis and Liver Disease
•
Antiviral Therapy in Immunocompromised Patients
Assessment

Assessment is via assignment submission.

Fee structure

The fee for the programme is as follows:

  • 1 month — Accelerated mode @ GBP £140
  • 2 months — Standard mode @ GBP £90
Accreditation
This program is not intended to replace or serve as an equivalent to obtaining a formal degree or diploma. It should be noted that this course is not accredited by a recognised awarding body or regulated by an authorised institution/ body.

Who delivers this course

Qualification
Advanced Certificate in Antiviral Therapeutics
Delivered by
London School of International Business (LSIB) · UKPRN 10062390
Awarded by
an Ofqual-regulated awarding body
Assessment
Written assignments, no exams
Support
Admissions team, 7 days a week

Your career in health & social care starts here

Flexible online study — enrol in minutes and begin when you are ready.

Apply now today